Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-009050
Filing Date
2021-04-15
Accepted
2021-04-15 17:09:39
Documents
1
Period of Report
2021-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4061
  Complete submission text file 0001437749-21-009050.txt   5631
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPPERTINO CA 95014
Business Address
Narayan Prabhu (Reporting) CIK: 0001829831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 21829282